Fundraising Fox

Craig Asher

Investor

Managing Director at OMX Ventures

Washington, District of Columbia

Writes $500K – $15M checks Β· typically $7.8M

FoundedGlyphic BiotechnologiesMatterworks

About

Craig Asher is a co-founder and managing partner of OMX Ventures, which he helped form in 2020. He previously worked as an early-stage biotech investor from 2009 to 2020, backing companies including QuantaLife, 10X Genomics, Twist Bioscience, Ginkgo Bioworks, and CD Diagnostics. Earlier in his career he worked as a manufacturing engineer and held roles at Trigo Technologies (later IBM), and he holds a degree from Stanford University plus an MBA and MS in Industrial Engineering from Northwestern University.

Invests in

Biotech

Experience

  1. OMX VenturesManaging Directorcurrent2020 β€” presentWashington, District of Columbia, United States
  2. Syndex BioBoard Observercurrent2025 β€” presentCambridgeshire, England, United Kingdom
  3. Constructive BioBoard Observercurrent2022 β€” presentCambridgeshire, England, United Kingdom
  4. Glyphic BiotechnologiesBoard Membercurrent2021 β€” presentSan Francisco Bay Area
  5. VedaBioBoard Membercurrent2021 β€” presentSan Diego, California, United States
  6. MatterworksBoard Membercurrent2020 β€” presentBoston, Massachusetts, United States
  7. Lightcast DiscoveryBoard Observercurrent2021 β€” presentCambridge, England, United Kingdom
  8. Merieux Equity PartnersStrategic Advisorcurrent2020 β€” present
  9. Aperiam BioBoard Observercurrent2022 β€” presentAustin, Texas, United States
  10. Menlo MicroBoard Observercurrent2016 β€” presentOrange County, California, United States
  11. Tessera TherapeuticsInvestorcurrent2020 β€” presentBoston, Massachusetts, United States
  12. Trancos VenturesManaging Partnercurrent2016 β€” presentWashington DC-Baltimore Area
  13. CircadenceBoard Membercurrent2012 β€” presentBoulder, CO
  14. Hexagon BioInvestorcurrent2017 β€” presentSan Francisco Bay Area
  15. Delix TherapeuticsInvestorcurrent2019 β€” presentBoston, Massachusetts, United States
  16. ManusInvestorcurrent2017 β€” presentPleasanton, California, United States
  17. 10x GenomicsInvestorcurrent2012 β€” presentPleasanton, California, United States
  18. SyntheX, Inc.Investorcurrent2017 β€” presentSan Francisco, CA
  19. Vital Venture Capital LLCPrincipalcurrent2008 β€” presentWashington DC-Baltimore Area
  20. ReplayInvestor2022 β€” 2026San Diego, California, United States

Education

  1. Northwestern UniversityMS, Industrial Engineering1993 β€” 1994
  2. Northwestern University - Kellogg School of ManagementMaster of Business Administration - MBA, Marketing1991 β€” 1993
  3. Stanford UniversityAB, Political Science1984 β€” 1988
  4. Heidelberg UniversityPolitischewissenschaft1988
  5. New Trier High1981 β€” 1984

Skills & more

Management19Leadership4Strategy27Negotiation1Strategic Planning5Product Management69Venture Capital56Product Development12Marketing6Quality Assurance2Start-ups93Product Marketing22
+12 moreStrategic PartnershipsEntrepreneurshipGo-to-market StrategyExecutive ManagementCloud ComputingCompetitive AnalysisMobile DevicesTelecommunicationsE-commerceAnalyticsDue DiligenceMergers & Acquisitions

Languages English Β· French Β· German Β· Italian Β· Spanish

From Craig's professional profile.

Same school

Shared employers

Investments

Investor

10X GenomicsCD DiagnosticsGinkgo BioworksQuantaLifeTwist Bioscience

Per the firm's website.

Colleagues at OMX Ventures

Network1

Investors connected to Craig in public investor directories β€” a warm-intro map.